证券代码：301206 证券简称：三元生物 公告编号：2025-065 山东三元生物科技股份有限公司 2025 年第三次临时股东大会通知公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东三元生物科技股份有限公司（以下简称"公司"）第五届董事会第七次 会议决定于 2025 年 7 月 31 日（星期四）召开公司 2025 年第三次临时股东大会， 现将本次会议有关事项通知如下： （三）会议召开的合法、合规性：本次股东大会会议召开符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 （四）会议召开的日期、时间： 1、现场会议召开时间：2025 年 7 月 31 日（星期四）15:00 2、网络投票时间：2025 年 7 月 31 日（星期四） （1）通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 7 月 31 日 9:15-9:25，9:30-11:30，13:00-15:00。 （2）通过深圳证券交易所互联网系统投票的时间为 2025 年 7 月 31 日 9:15-15:00 （五）会议的召开方式：本次股东大会采用现场表决与 ...

Group 1 - The company Chutianlong is actively exploring and promoting the implementation of digital currency bridge scenarios, but faces risks related to new technology research and development and commercial application not meeting expectations [6] - Sanwei Biological received the preliminary ruling result of the anti-dumping investigation on erythritol from the US Department of Commerce, with a 450.64% anti-dumping duty applicable to the company [6] Group 2 - Sitwei expects a year-on-year net profit increase of 140% to 180% for the first half of the year [7] - Pop Mart anticipates a profit growth of no less than 350% for the six months ending June 30, 2025, compared to the same period last year [7] - Zhongsheng High-Tech is planning a change in company control, with its stock suspended from trading starting July 16 [7] - Sinochem International intends to acquire 100% equity of Nantong Xingchen, with its stock also suspended from trading starting July 16 [7] - *ST Yazhen's stock is under suspension for verification due to abnormal trading fluctuations starting July 16 [7] - Yanshan Technology's wholly-owned subsidiary is participating in the establishment of a partnership, which will ultimately invest in Bytedance Ltd. in equity form [7] - Bertley plans to jointly establish a partnership with Jinding Private Equity, focusing on investments in unlisted companies in the field of humanoid robots [7] - *ST Weir intends to purchase 51% of Zijiang New Materials for 546 million yuan, entering the lithium battery materials industry [7] - Dahua Technology's controlling subsidiary Huairui Technology is adjusting to be listed on the Hong Kong Stock Exchange [7]

Key Points - Zhongsheng Gaoke is planning a change in company control, with a potential transfer of 22.35% of shares at a valuation of 2.5 billion yuan, leading to a stock suspension starting July 16, 2025 [3][4] - Yanshan Technology's subsidiary is participating in a partnership to invest 41.64 million yuan in a fund that will ultimately invest in Bytedance Ltd [5] - Sanyuan Bio received an initial ruling of a 450.64% anti-dumping duty from the US Department of Commerce on erythritol, prompting a shift in sales strategy towards domestic markets [6] - Chutianlong is exploring digital currency projects but faces risks related to new technology development and commercial application [7] - Bertley is establishing a partnership to invest in humanoid robots and other emerging sectors, committing 198 million yuan [8] - China Merchants Highway's chairman resigned due to reaching retirement age [9] - Tibet Summit's controlling shareholder is under investigation for information disclosure violations, but it will not affect the company's operations [10][11] - ST Weir plans to acquire 51% of Zijiang New Materials for 546 million yuan, entering the lithium battery materials sector [12] - ST Yazhen's stock will be suspended for three days due to abnormal trading fluctuations [13] - Dahua Technology's subsidiary is shifting its listing to the Hong Kong Stock Exchange [14] Performance Forecasts - Zhongji Xuchuang expects a net profit increase of 52.64% to 86.57% for the first half of 2025, driven by strong demand for high-end optical modules [15] - Juchip Technology anticipates a 122.28% increase in net profit for the same period, benefiting from successful AI audio chip promotions [16] - Sitwei forecasts a net profit growth of 140% to 180%, with significant revenue increases from smartphone collaborations [17] - Tianyu Co. expects a net profit increase of 144.29% to 238.25%, aided by improved product structure and market strategies [18] - Jinli Yongci predicts a net profit growth of 151% to 180%, focusing on renewable energy and related sectors [19] - Blue Ocean Huaten expects a net profit increase of 152.76% to 190.68%, driven by growth in the new energy heavy truck market [20] - Maiqu'er anticipates a turnaround with a net profit of 1.4 million to 2 million yuan, compared to a loss in the previous year [21] - China Galaxy expects a net profit increase of 45% to 55%, with growth across various business segments [23] - Baicheng Pharmaceutical forecasts a significant decline in net profit, down 95.53% to 100% [24] Major Contracts - Jincheng signed a contract worth approximately 52.98 million USD for underground mining operations in the Democratic Republic of Congo [25] - ST Yundong entered a strategic cooperation agreement for drone development and investment with two companies [26] - Changgao Electric New's subsidiary won contracts totaling 445 million yuan from the State Grid [27] Shareholding Changes - Angli Education plans to reduce its repurchased shares by up to 573.1 million shares [28][29] - Lingzhi Software's shareholders plan to collectively reduce their holdings by up to 2.11% [30] - Founder Technology's major shareholder intends to reduce its stake by up to 2.27% [31] - Zhongfu Shenying's shareholder plans to reduce its stake by up to 1% [32] - Hangzhou Bank's shareholder intends to reduce its stake by up to 0.7% [33] - Haoyun Technology's chairman plans to reduce his stake by up to 400,000 shares [34] Financing Activities - Yuanwang Valley plans to raise up to 300 million yuan through a private placement for RFID production line projects and working capital [35]

Core Viewpoint - The U.S. Department of Commerce has initiated anti-dumping investigations against Chinese erythritol, significantly impacting companies like Sanyuan Biotech, which faces a preliminary anti-dumping tax of 450.64% [1] Company Summary - Sanyuan Biotech has acknowledged that the ongoing anti-dumping and countervailing investigations by the U.S. have affected its sales in the American market, with the extent of future impacts still to be assessed based on the investigation's progress and market changes [1] - The company is shifting its sales strategy from an export-focused approach to a balanced domestic and international strategy, emphasizing the domestic health consumer market and developing B-end clients [1] - Sanyuan Biotech is launching "Yuansheng Sweet" small-packaged sugar products to enhance consumer awareness of healthy sugar alternatives [1] Industry Summary - Erythritol is a low-calorie sweetener widely used in "zero-sugar" foods and beverages, known for its low sweetness, minimal risk of cavities, low blood sugar impact, high stability, and good taste [1] - The U.S. Department of Commerce is expected to release the final ruling on the anti-dumping investigation by November 23, 2025, while the final ruling on the countervailing investigation is anticipated by September 24, 2025 [3] - The erythritol industry is facing multiple international trade challenges, including anti-dumping investigations from both the U.S. and the EU, with the EU imposing anti-dumping duties ranging from 34.4% to 233.3% effective from January 17, 2025 [3] - The erythritol industry is projected to enter a capacity clearing phase starting in 2024, with prices expected to recover and gross margins increasing from 1.1% to a range of 8.3% to 14.2% [3] - The domestic market for erythritol is anticipated to grow due to increasing health consumption awareness, with significant recovery in profitability expected in 2024 [4]

| 第一章 | 总则 2 | | --- | --- | | 第二章 | 经营宗旨和范围 3 | | 第三章 | 股份 3 | | 第一节 | 股份发行 3 | | 第二节 | 股份增减和回购 4 | | 第三节 | 股份转让 5 | | 第四章 | 股东和股东大会 6 | | 第一节 | 股东 6 | | 第二节 | 股东大会的一般规定 8 | | 第三节 | 股东大会的召集 11 | | 第四节 | 股东大会的提案与通知 12 | | 第五节 | 股东大会的召开 14 | | 第六节 | 股东大会的表决和决议 16 | | 第五章 | 董事会 21 | | 第一节 | 董事 21 | | 第二节 | 董事会 23 | | 第六章 | 总经理及其他高级管理人员 28 | | 第七章 | 监事会 30 | | 第一节 | 监事 30 | | 第二节 | 监事会 30 | | 第八章 | 财务会计制度、利润分配和审计 32 | | 第一节 | 财务会计制度 32 | | 第二节 | 内部审计 35 | | 第三节 | 会计师事务所的聘任 36 | | 第九章 | 通知和公告 36 | | 第一节 | 通知 36 ...

证券代码：301206 证券简称：三元生物 公告编号：2025-064 山东三元生物科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东三元生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 15 日召开了第五届董事会第七次会议、第五届监事会第七次会议，审议通过了《关 于增加公司经营场所及修订<公司章程>的议案》。现将具体情况公告如下： 一、增加经营场所情况 为满足公司经营发展需要，结合当前实际情况，公司拟增加以下经营场所， 具体地址为：滨州市滨北梧桐十路 102 号。 二、《公司章程》修订情况 鉴于公司拟增加经营场所的相关情况，根据《公司法》《上市公司章程指引》 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等法律法规、规范性文件的规定，拟对 《山东三元生物科技股份有限公司章程》（以下简称"公司章程"）中的相关条款 进行修订。具体修订内容如下： | 序号 | 修订前 | 修订后 | | --- | --- | --- | | | 第五条 公司住所：滨州市滨北张富 ...

证券代码：301206 证券简称：三元生物 公告编号：2025-065 （四）会议召开的日期、时间： 1、现场会议召开时间：2025 年 7 月 31 日（星期四）15:00 山东三元生物科技股份有限公司 2025 年第三次临时股东大会通知公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东三元生物科技股份有限公司（以下简称"公司"）第五届董事会第七次 会议决定于 2025 年 7 月 31 日（星期四）召开公司 2025 年第三次临时股东大会， 现将本次会议有关事项通知如下： 一、召开会议的基本情况 （一）股东大会届次：2025 年第三次临时股东大会 （二）股东大会的召集人：公司董事会。 （三）会议召开的合法、合规性：本次股东大会会议召开符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 2、网络投票时间：2025 年 7 月 31 日（星期四） （1）通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 7 月 31 日 9:15-9:25，9:30-11:30，13:00-15:00。 （2）通过深圳证券交易所互联网系统投 ...

证券代码：301206 证券简称：三元生物 公告编号：2025-063 山东三元生物科技股份有限公司 第五届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开和出席情况 山东三元生物科技股份有限公司（以下简称"公司"）第五届监事会第七次 会议于 2025 年 7 月 15 日下午 2:30 在公司会议室以现场方式召开。会议通知于 7 月 11 日以书面、电话方式通知到各位监事，本次会议应到监事 3 人，实到监事 3 人，会议由监事会主席阎光浩主持，会议的召集、召开和表决程序符合《公司 法》和《公司章程》的有关规定，所作决议合法有效。 二、议案审议情况 本次会议以记名投票表决方式表决通过如下议案： （一）审议通过《关于增加公司经营场所及修订<公司章程>的议案》。 为满足公司经营发展需要，结合当前实际情况，公司拟增加以下经营场所， 具体地址为：滨州市滨北梧桐十路 102 号，同时对《公司章程》相关条款进行修 订，并提请股东大会授权管理层办理工商变更备案登记手续，本次拟增加的经营 场所及相关章程条款修订内容最终以市场监督管理部门核 ...

证券代码：301206 证券简称：三元生物 公告编号：2025-062 山东三元生物科技股份有限公司 本次会议以记名投票表决方式表决通过如下议案： （一）审议通过《关于增加公司经营场所及修订<公司章程>的议案》； 为满足公司经营发展需要，结合当前实际情况，公司拟增加以下经营场所， 具体地址为：滨州市滨北梧桐十路 102 号，同时对《公司章程》相关条款进行修 订，并提请股东大会授权管理层办理工商变更备案登记手续，本次拟增加的经营 场所及相关章程条款修订内容最终以市场监督管理部门核准登记结果为准。 第五届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开和出席情况 山东三元生物科技股份有限公司（以下简称"公司"）第五届董事会第七次 会议于 2025 年 7 月 15 日上午 9:30 在公司会议室以现场+视频方式召开。会议通 知于 7 月 11 日以书面、电话方式通知到各位董事，本次会议应到董事 9 人，实 到董事 9 人，会议由董事长聂在建主持，董事会秘书、总经理、总工程师、财务 总监、全体监事列席本次会议。会议的召集、召开和 ...

2025 年 7 月 15 日，公司收到美国商务部关于本次赤藓糖醇反倾销调查初裁 结果，公司作为强制应诉企业，适用 450.64%的反倾销税。目前，反倾销调查尚 未结束，上述结果仅为初裁结果，美国商务部尚需进一步核查后作出最终裁定。 三、对公司的影响 证券代码：301206 证券简称：三元生物 公告编号：2025-066 山东三元生物科技股份有限公司 关于美国对中国赤藓糖醇反倾销调查初裁结果的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东三元生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 15 日 获悉，美国商务部公布了对原产于中国的赤藓糖醇产品反倾销调查的初裁结果。 现将具体情况公告如下： 一、情况介绍 美国生产商 Cargill, Incorporated 公司于美国时间 2024 年 12 月 13 日向美国 商务部和美国国际贸易委员会提交申请，要求对原产于中国的赤藓糖醇产品启动 反倾销和反补贴调查。本次涉案产品在美国协调关税表（HTSUS）中的分类为子 目 2905.49.4000 和 2106.90.9998（前述税则号 ...